McFadden E R, Kiser R, deGroot W J, Holmes B, Kiker R, Viser G
Am J Med. 1976 Jan;60(1):52-9. doi: 10.1016/0002-9343(76)90533-7.
To evaluate the effects of corticosteroids on the resolution of acute attacks of asthma, 38 young, acutely ill, asthmatic subjects were given a single intravenous injection of either 0.25, 0.50 or 1.0 g of hydrocortisone hemisuccinate or a placebo (sterile saline solution) in a random, double blind manner. Each was then treated with isoproterenol, at hourly intervals, for a minimum of six hours, and the serial changes in plethysmography, spirometry, lung volumes, subjective complaints and physical findings that occurred as the patients improved were observed. No statistical differences were found in any of the physiologic or clinical variables between those patients given any dose of steroids and their matched controls. From this it has been concluded that hydrocortisone, in the doses and route of administration employed, does not produce any immediate benefits in the treatment of acute asthma.
为评估皮质类固醇对哮喘急性发作缓解的影响,38名年轻、急性发病的哮喘患者被随机、双盲地单次静脉注射0.25克、0.50克或1.0克半琥珀酸氢化可的松或安慰剂(无菌盐溶液)。然后每小时用异丙肾上腺素治疗,至少治疗6小时,并观察随着患者病情改善而出现的体积描记法、肺量计、肺容量、主观症状和体格检查结果的系列变化。在给予任何剂量类固醇的患者与其匹配的对照组之间,在任何生理或临床变量上均未发现统计学差异。由此得出结论,在所采用的剂量和给药途径下,氢化可的松在治疗急性哮喘中不会产生任何即时益处。